117 related articles for article (PubMed ID: 3361352)
21. [Correlation between anti-tumor effect and delayed hypersensitivity induced by topically applied OK-432 with histological findings].
Kokunai I; Mori T; Yayoi E; Matuura N; Kosaki G
Nihon Geka Gakkai Zasshi; 1985 Mar; 86(3):258-65. PubMed ID: 3982380
[TBL] [Abstract][Full Text] [Related]
22. In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432.
Wakasugi H; Kasahara T; Minato N; Hamuro J; Miyata M; Morioka Y
J Natl Cancer Inst; 1982 Oct; 69(4):807-12. PubMed ID: 6181282
[TBL] [Abstract][Full Text] [Related]
23. OK-432 stimulates primary production and activity of murine natural killer cells.
Pollack SB
Nat Immun Cell Growth Regul; 1987; 6(5):224-36. PubMed ID: 3444437
[TBL] [Abstract][Full Text] [Related]
24. [A case of advanced gastric cancer responsive to intratumoral OK-432 injection].
Sakai Y; Maeda M; Koyama W; Totsuka S; Sakamoto S; Kanayama M
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1978-80. PubMed ID: 3382244
[TBL] [Abstract][Full Text] [Related]
25. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.
Weiner LM; Holmes M; Adams GP; LaCreta F; Watts P; Garcia de Palazzo I
Cancer Res; 1993 Jan; 53(1):94-100. PubMed ID: 8093231
[TBL] [Abstract][Full Text] [Related]
26. Adoptive immunotherapy by pantropic killer cells recovered from OK-432-injected tumor sites in mice.
Saito M; Nanjo M; Kataoka M; Moriya Y; Sugawara Y; Yoshida T; Ishida N
Cancer Res; 1988 Aug; 48(15):4163-7. PubMed ID: 3390809
[TBL] [Abstract][Full Text] [Related]
27. Salmonella typhimurium induces IFN-gamma production in murine splenocytes. Role of natural killer cells and macrophages.
Ramarathinam L; Niesel DW; Klimpel GR
J Immunol; 1993 May; 150(9):3973-81. PubMed ID: 8473744
[TBL] [Abstract][Full Text] [Related]
28. Modulation of NK activity in regional lymph nodes by preoperative immunotherapy with OK-432 in patients with cancer of the oral cavity.
Vinzenz K; Matejka M; Watzek G; Porteder H; Neuhold N; Micksche M
Cancer Detect Prev Suppl; 1987; 1():463-75. PubMed ID: 3480060
[TBL] [Abstract][Full Text] [Related]
29. [In vivo augmentation of natural killer (NK) cell activity by a streptococcal preparation, OK-432: characterization of effector cells and induction of interferon in sera (author's transl)].
Wakasugi H; Miyata M; Morioka Y; Oshimi K; Kasahara T; Takahashi K; Saito M; Ebina T
Nihon Gan Chiryo Gakkai Shi; 1981 Jun; 16(3):433-46. PubMed ID: 7320603
[No Abstract] [Full Text] [Related]
30. Splenectomy abolishes antitumor effect of immunotherapy with streptococcal preparation, OK-432, on mouse liver tumors.
Imai S; Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Kawabata K; Masai Y; Tobe T
Anticancer Res; 1991; 11(3):1269-74. PubMed ID: 1888159
[TBL] [Abstract][Full Text] [Related]
31. Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed streptococcal preparation.
Saito M; Ichimura O; Kataoka M; Moriya Y; Ueno K; Sugawara Y; Nanjo M; Ishida N
Cancer Immunol Immunother; 1986; 22(3):161-8. PubMed ID: 2425968
[TBL] [Abstract][Full Text] [Related]
32. [Effective mechanisms of BRM, with special reference to induction of autologous tumor cell-killing (ATK) activity by OK-432].
Hoshino T; Uchida A
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1277-84. PubMed ID: 3488024
[TBL] [Abstract][Full Text] [Related]
33. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
Arteaga CL; Hurd SD; Winnier AR; Johnson MD; Fendly BM; Forbes JT
J Clin Invest; 1993 Dec; 92(6):2569-76. PubMed ID: 7504687
[TBL] [Abstract][Full Text] [Related]
34. Studies on the immunopotentiating effects of a streptococcal preparation, OK-432. I. Enhancement of T cell-mediated immune responses of mice.
Kai S; Tanaka J; Nomoto K; Torisu M
Clin Exp Immunol; 1979 Jul; 37(1):98-105. PubMed ID: 314874
[TBL] [Abstract][Full Text] [Related]
35. Enhanced generation of OK-432-induced killer cells by interleukin 2.
Ujiie T
Jpn J Exp Med; 1987 Jun; 57(3):183-8. PubMed ID: 3500332
[TBL] [Abstract][Full Text] [Related]
36. Radiolocalization of xenografted human lung cancer with monoclonal antibody 8 in nude mice.
Endo K; Kamma H; Ogata T
Cancer Res; 1987 Oct; 47(20):5427-32. PubMed ID: 3652045
[TBL] [Abstract][Full Text] [Related]
37. Alloantigen-activated lymphocytes from mice bearing a spontaneous "nonimmunogenic" adenocarcinoma inhibit its growth in vivo by recruiting host immunoreactivity.
Giovarelli M; Santoni A; Forni G
J Immunol; 1985 Nov; 135(5):3596-603. PubMed ID: 3930610
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical studies on local antitumor effects of streptococcal immunopotentiator, OK-432, in human solid malignant tumors.
Sugenoya A; Usuda N; Adachi W; Kaneko G; Nagata T; Iida F
Arch Pathol Lab Med; 1988 May; 112(5):545-9. PubMed ID: 3282486
[TBL] [Abstract][Full Text] [Related]
39. [Induction and measurement of delayed hypersensitivity to OK-432].
Kohunai I; Mori T; Yayoi E; Kosaki G
Nihon Geka Gakkai Zasshi; 1984 Nov; 85(11):1387-92. PubMed ID: 6521720
[TBL] [Abstract][Full Text] [Related]
40. Effect of OK-432 on the lymphnode metastasis of MCA-sarcoma cell lines: a new therapeutic approach.
Inoh A; Kodama Y; Yokoro K
Hiroshima J Med Sci; 1989 Dec; 38(4):213-9. PubMed ID: 2637250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
